The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

Table 1 Summary of prevalence results by age grouping

Age Group	First author & publication year	Geography	Number DMD identified	Prevalence date	Mean prevalence per 100,000	Type of prevalence
Newborn	Mendell, 2012 [2]	Ohio	6	2007–2011	15.9	Birth
Newborn	Moat, 2013 [3]	Wales	72	1990–2011	19.5	Birth
Boys aged 5 to 9	Romitti, 2015 [14]	USA	111	1991–1995	14.3	5 - year
			117	1996–2000	14.6
			127	2001–2005	16.0
			141	2006–2010	11.8
Boys aged 5 to 24	Romitti, 2015 [14]	USA	389	2010	10.2	Point
Males under 18	Rasmussen, 2012 [13]	SE Norway	33	2005	16.2
Males 0 to 24	Mah, 2011 [15]	Canada	529	2000–2009	10.3
All Males	Norwood FL, 2009 [12]	Northern England	124	2007	8.3
	Bladen 2013 [16]*	France	3337	2012	10.9
		USA	2833	2012	1.8
		UK	666	2012	2.2
		Canada	1020	2012	6.1

ISSN: 1750-1172